Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crisaborole maintenance regimen study in childhood atopic dermatitis
ChiCTR2300068426Phase 4Recruiting
- Sponsor
- Beijing Children's Hospital
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of crisaborole in atopic dermatitis (AD) (2 arms), sponsored by Beijing Children's Hospital. Primary endpoints: Investigator's Static Global Assessment, Recurrence rate and 1 more. Started Oct 2021; status: recruiting.
02
Drugs
crisaborole
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on ChiCTR2300068426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300068426.